• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 7
  3. Author

Online ISSN: 2515-8260

Volume9, Issue7

Clinico-radiological profile and outcome of patients with posterior reversible encephalopathy syndrome

    Basavaraj P G, Sidaraya Hanjagi

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 7, Pages 2915-2919

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: Posterior reversible encephalopathy syndrome (PRES) is usually diagnosed according to the presence of typical neuroimage showing vasogenic edema predominately involving the posterior brain area. Present study was aimed to study clinicoradiological profile and outcome of patients with posterior reversible encephalopathy syndrome at our tertiary hospital.
Material and Methods: Present study was retrospective, case-record based study, conducted in patients with clinical and imaging features suggestive of PRES.
Results: 32 case records were studied. Mean age was 39.8 ± 10.7 years. Male (34.38 %) to female (65.63 %) ratio was 1: 0.52. Common clinical features noted were seizure (71.88 %), headache (68.75 %), altered mental status (59.38 %), vomiting (34.38 %), fever (25 %) & visual impairments (18.75 %). Eclampsia (50 %) was most common etiology for PRES, followed by hypertension (18.75 %), renal diseases (15.63 %), postpartum sepsis (9.38 %), poly-trauma (3.13 %) & cardiac disease (3.13 %). MRI Neuroimaging finding in study were involvement of parieto-occipital lobes (65.63 %), subcortical (46.88 %), frontal lobe (34.38 %), temporal lobe (18.75 %), asymmetric involvement of brain (18.75 %), cerebellum (12.50 %), basal ganglia (9.38 %), cortical (9.38 %), subarachnoid bleed (6.25 %), brainstem (3.13 %) & deep white matter (3.13 %), Mortality was observed in 2 cases (6.25 %) (both were antepartum eclampsia, reported to hospital in unconscious state & required intubation on admission). Good prognosis was noted in 30 cases (93.75 %). Conclusion: Early recognition of PRES is associated with good prognosis & good recovery, particularly if underlying etiology is treated satisfactorily.
Keywords:
    Eclampsia PRES Hypertension MRI imaging
  • PDF (211 K)
  • XML
(2022). Clinico-radiological profile and outcome of patients with posterior reversible encephalopathy syndrome. European Journal of Molecular & Clinical Medicine, 9(7), 2915-2919.
Basavaraj P G, Sidaraya Hanjagi. "Clinico-radiological profile and outcome of patients with posterior reversible encephalopathy syndrome". European Journal of Molecular & Clinical Medicine, 9, 7, 2022, 2915-2919.
(2022). 'Clinico-radiological profile and outcome of patients with posterior reversible encephalopathy syndrome', European Journal of Molecular & Clinical Medicine, 9(7), pp. 2915-2919.
Clinico-radiological profile and outcome of patients with posterior reversible encephalopathy syndrome. European Journal of Molecular & Clinical Medicine, 2022; 9(7): 2915-2919.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 30
  • PDF Download: 60
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus